EFFECT OF SYNERGY OF COLISTIN / VANCOMYCIN AGAINST STRAINS OF ACINETOBACTER BAUMANNII BY E-TEST METHOD IN RABAT
*Es-Said Imane, Ousti Fadwa, Zouhdi Mimoun
ABSTRACT
Multidrug-resistant Acinetobacter baumannii (MDRAB) presents a
major health problem. Although colistin has-been used as a treatment
of last resort, but it was still considered as a nephrotoxic antibiotic. The
mechanism of Action of colistin, however, raises the possibility of
synergy with other molecules that are normally inactive against Gramnegative
organisms by virtue of the impermeability of the bacterial
outer membrane. This study evaluated the effect of colistin combined
with vancomycin on fifty strains of A. baumannii multiresistant,
except for colistin, by using Etest methods. For all the isolates,
significant synergy was demonstrated with reductions in the MIC of vancomycin from> 256
mcg / ml to ≤ 12 mg / ml for all strains after exposure to 0.5 mg / ml colistin. This raises the
possibility of the clinical use of this combination for infections due to MDRAB, with the
potential for doses lower than those currently used.
Keywords: Colistin, vancomycin, synergy, Acinetobacter baumannii
[Download Article]
[Download Certifiate]